New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
'We Are Not Animals...': Bad Bunny Speaks Out Against ICE At Grammys 2026 After Win, Gets Standing Ovation- VIDEO
Markets Rebound 300 Points, Sensex Above 81,000 After Budget Shock
Mumbai Weather Update February 2, 2026: Smog Blankets City As AQI Remains ‘Severe’; Wadala & Sewri Worst Affected
'4 Din Baad Waapsi...': Sunil Gavaskar Brutally Trolls Pakistan On IND vs PAK Match Boycott Amid ICC T20 World Cup 2026 Row
